Jiang YongWei, Ma Liang, Han ChengWu, Liu Qian, Cong Xiao, Xu YaPing, Zhao TingTing, Li Ping, Cao YongTong
Clinical Laboratory, China-Japan Friendship Hospital, Beijing, China.
Graduate School of Peking Union Medical College, Beijing, China; Beijing Key Lab Immune-Mediated Inflammatory Diseases, Institute of Clinical Medical Science, China-Japan Friendship Hospital, Beijing, China.
J Diabetes Res. 2017;2017:3560920. doi: 10.1155/2017/3560920. Epub 2017 Feb 23.
Diabetic nephropathy (DN) is one of the major chronic complications of diabetes. Genetic polymorphism of Apolipoprotein E (ApoE) has been proposed to participating in DN. The purpose of the study was to evaluate the relationship between ApoE genetic polymorphism and the presence of DN in Chinese type 2 diabetic patients. We studied 845 diabetic patients who were divided into DN group ( = 429) and control group ( = 416). ApoE genotype was determined by ApoE genotyping chip and the plasmatic biochemical characterization was performed on all subjects. There were differences ( < 0.001) in HbA1c, creatinine, and urinary albumin between the two groups. The ApoE 2 allelic frequency was 7.69% in DN group versus 3.49% in control group (OR = 2.22, 95% CI = 1.41-3.47, and < 0.05), as expected, ApoE E2/E2 and E2/E3 genotype frequency were higher in DN group (13.75% versus 6.49%, < 0.05). The ApoE 4 allelic frequency was 7.93% in DN group versus 11.54% in control group (OR = 0.70, 95% CI = 0.50-0.97, and < 0.05), and DN group presented a lower frequency of ApoE E3/E4 and E4/E4 genotype frequency (14.91% versus 19.96%, < 0.05). These results suggest ApoE 2 allele may be a risk factor; however ApoE 4 allele may play a protective role of DN in Chinese type 2 diabetic patients.
糖尿病肾病(DN)是糖尿病的主要慢性并发症之一。载脂蛋白E(ApoE)基因多态性被认为与糖尿病肾病有关。本研究旨在评估中国2型糖尿病患者中ApoE基因多态性与糖尿病肾病的关系。我们研究了845例糖尿病患者,将其分为糖尿病肾病组(n = 429)和对照组(n = 416)。通过ApoE基因分型芯片确定ApoE基因型,并对所有受试者进行血浆生化特征分析。两组之间糖化血红蛋白、肌酐和尿白蛋白存在差异(P < 0.001)。糖尿病肾病组ApoE 2等位基因频率为7.69%,对照组为3.49%(OR = 2.22,95%CI = 1.41 - 3.47,P < 0.05),正如预期的那样,糖尿病肾病组ApoE E2/E2和E2/E3基因型频率更高(13.75%对6.49%,P < 0.05)。糖尿病肾病组ApoE 4等位基因频率为7.93%,对照组为11.54%(OR = 0.70,95%CI = 0.50 - 0.97,P < 0.05),糖尿病肾病组ApoE E3/E4和E4/E4基因型频率较低(14.91%对19.96%,P < 0.05)。这些结果表明,ApoE 2等位基因可能是一个危险因素;然而,ApoE 4等位基因可能对中国2型糖尿病患者的糖尿病肾病起到保护作用。